Jochen is the Chief Scientific Officer (CSO) and Co-founder of LoopLab. With over 20 years of experience in industrial and academic research, his expertise is focused on cancer immunotherapy, infectious diseases, molecular imaging, biomarkers, and translational research. Throughout his career, Jochen has held senior research roles, including Senior Principal Scientist at MSD, where he led the oncolytic virus and vaccine programs. He joined MSD following the acquisition of Themis Bioscience where he was Senior Vice President Immunotherapy. Prior to Themis, Jochen worked at Genelux in positions of increasing responsibility including Associate VP of Research where he was responsible for the company’s cancer immunotherapy research as well as strategic partnerships. Jochen holds a PhD in Biology and a bachelor’s in biology and microbiology from the University of Würzburg.

Simona is the Chief of Operations (COO) and Co-founder of LoopLab, bringing over 15 years of experience in pharmaceutical operations, quality management, and regulatory compliance. She combines expertise in GMP, batch release, and quality assurance with finance, business development, and HR. Previously, she held leadership roles at Themis Bioscience, Alcon, Croma and Kwizda Pharmadistribution. As Head of Quality Assurance at Themis, she led regulatory strategy, while at Alcon, she optimized quality systems. As a Qualified Person (QP) at Kwizda, she managed batch release with a high level of responsibility. Simona began her career at Baxter BioScience and holds a Magister’s degree in Biology from Paris Lodron University Salzburg and an MBA from FH Burgenland. Her expertise in quality, finance, HR and business operations supports LoopLab’s mission to drive innovation with excellence.

Eva is the Chief Development Officer (CDO) of LoopLab, with over 15 years of experience in biomedical research, drug development, and clinical strategy. She has a strong background in molecular biology and translational research, advancing innovative therapies for immunological and neurodegenerative diseases. Before joining LoopLab, Eva held leadership roles at Evotec, Valneva, and AFFiRiS AG, driving biologics from discovery to clinical development. At Evotec, she led gene therapy platform development, integrating AI/ML-driven vector engineering. At Valneva, she shaped clinical strategy and study design, while at AFFiRiS AG, she led preclinical programs for therapeutic vaccines in Alzheimer’s and Parkinson’s disease. Eva holds a PhD in Molecular Biology from the University of Vienna and has authored multiple scientific publications. Her expertise in drug development and clinical research supports LoopLab’s mission to develop breakthrough therapies.